• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N 端脑利钠肽前体水平作为一种筛查工具,用于检测源于心脏外疾病的儿科疾病中的心脏受累情况。

N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin.

机构信息

Department of Paediatrics, Children's Hospital, London Health Science Centre, University of Western Ontario, 800 Commissioners Road East, London, ON N6A 5W9, Canada.

出版信息

Clin Res Cardiol. 2011 Sep;100(9):723-30. doi: 10.1007/s00392-011-0317-0. Epub 2011 Apr 14.

DOI:10.1007/s00392-011-0317-0
PMID:21487941
Abstract

BACKGROUND

Serum concentrations of N-terminal natriuretic pro-brain natriuretic peptide (NT-proBNP) correlate well with the severity of cardiac disease in children and adults. There are also paediatric illnesses of extracardiac origin that may cause deterioration of the cardiac function in some patients (pts). A high NP level can signify a concomitant cardiac involvement in respiratory distress, or secondary to a systemic disease.

OBJECTIVE

To assess the potential of NT-proBNP as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin.

METHODS

A literature search was performed in PubMed for the relevant studies with the subject brain natriuretic peptide (BNP) and NT-proBNP from 1995 to 2010 with stress on characteristics of the natriuretic peptides, paediatric reference values and systemic paediatric diseases with potential influence on the myocardial performance. The main focus has been NT-proBNP being the most stable NP and correlating well with BNP.

RESULTS

Most studies agree that a high NT-proBNP level indicates cardiac dysfunction in different systemic diseases such as thalassemia and cystic fibrosis or in pts after chemotherapy. In special clinical scenarios as sepsis or respiratory distress, NT-proBNP helps to narrow down the differential diagnosis or can be used for risk stratification.

CONCLUSION

NT-proBNP can serve as a screening tool in various primarily non-cardiac paediatric diseases. Together with the clinical picture, a high level suggests further assessment by a paediatric cardiologist.

摘要

背景

血清 N 端脑利钠肽前体(NT-proBNP)浓度与儿童和成人心脏病的严重程度密切相关。也有一些起源于心脏外的儿科疾病可能导致某些患者的心脏功能恶化(pts)。高 NP 水平可能表示在呼吸窘迫中伴有心脏受累,或者继发于全身性疾病。

目的

评估 NT-proBNP 作为儿科心脏外疾病中心脏受累的筛查工具的潜力。

方法

在 PubMed 上进行了文献检索,检索了 1995 年至 2010 年与脑利钠肽(BNP)和 NT-proBNP 相关的研究,重点关注利钠肽的特征、儿科参考值以及可能影响心肌功能的全身性儿科疾病。主要重点是 NT-proBNP 是最稳定的 NP,与 BNP 相关性良好。

结果

大多数研究都认为,高 NT-proBNP 水平表明不同的全身性疾病(如地中海贫血和囊性纤维化)或化疗后的患者存在心脏功能障碍。在特殊的临床情况下,如脓毒症或呼吸窘迫,NT-proBNP 有助于缩小鉴别诊断范围,或可用于风险分层。

结论

NT-proBNP 可作为各种主要非心脏儿科疾病的筛查工具。结合临床表现,高水平提示需要由儿科心脏病专家进一步评估。

相似文献

1
N-terminal pro-brain natriuretic peptide level as a screening tool for cardiac involvement in paediatric diseases of extracardiac origin.N 端脑利钠肽前体水平作为一种筛查工具,用于检测源于心脏外疾病的儿科疾病中的心脏受累情况。
Clin Res Cardiol. 2011 Sep;100(9):723-30. doi: 10.1007/s00392-011-0317-0. Epub 2011 Apr 14.
2
Midregional pro-atrial natriuretic peptide for the diagnosis of cardiac-related dyspnea according to renal function in the emergency department: a comparison with B-type natriuretic peptide (BNP) and N-terminal proBNP.中段心房利钠肽在急诊根据肾功能诊断与心脏相关的呼吸困难中的应用:与 B 型利钠肽(BNP)和 N 末端 proBNP 的比较。
Clin Chem. 2010 Nov;56(11):1708-17. doi: 10.1373/clinchem.2010.145417. Epub 2010 Sep 2.
3
Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.脑利钠肽和 N 端脑利钠肽检测儿科肺动脉高压的准确性:系统评价和荟萃分析。
Ann Med. 2024 Dec;56(1):2352603. doi: 10.1080/07853890.2024.2352603. Epub 2024 May 16.
4
Decreasing ratio of plasma N-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide according to age.血浆N末端B型利钠肽原与B型利钠肽的比值随年龄降低。
Acta Paediatr. 2006 Jul;95(7):805-9. doi: 10.1080/08035250500466647.
5
N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease.健康献血者以及来自全科医生处的、已诊断和未诊断出心脏病的患者体内的N端前脑钠肽(NT-proBNP)
Clin Lab. 2005;51(3-4):167-72.
6
[Value of N-terminal pro-brain natriuretic peptide in evaluating early septic cardiac dysfunction in neonates].N末端脑钠肽前体在评估新生儿早期脓毒症性心功能障碍中的价值
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 Jun;32(6):711-715. doi: 10.3760/cma.j.cn121430-20191122-00065.
7
Clinical implications of B-type natriuretic peptide and N-terminal pro--B-type natriuretic peptide in the care of the vascular surgery patient.B型利钠肽和N末端前B型利钠肽在血管外科患者护理中的临床意义。
Semin Vasc Surg. 2014 Dec;27(3-4):143-7. doi: 10.1053/j.semvascsurg.2015.01.004. Epub 2015 Jan 21.
8
B-type natriuretic peptide (BNP) and N-terminal-proBNP for heart failure diagnosis in shock or acute respiratory distress.B型利钠肽(BNP)和N末端前脑钠肽原用于休克或急性呼吸窘迫时心力衰竭的诊断。
Acta Anaesthesiol Scand. 2006 Mar;50(3):340-7. doi: 10.1111/j.1399-6576.2006.00963.x.
9
Influence of renal function on N-terminal pro-brain natriuretic peptide (NT-proBNP) in patients admitted for dyspnoea in the Emergency Department: comparison with brain natriuretic peptide (BNP).肾功能对急诊科因呼吸困难入院患者N末端前脑钠肽(NT-proBNP)的影响:与脑钠肽(BNP)的比较
Clin Chim Acta. 2005 Nov;361(1-2):167-75. doi: 10.1016/j.cccn.2005.05.021.
10
[Values of brain natriuretic peptide and N-terminal pro-brain natriuretic peptide in evaluation of cardiac function in children with congenital heart disease].[脑钠肽及N末端脑钠肽原在先天性心脏病患儿心功能评估中的价值]
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Jun;11(6):429-32.

引用本文的文献

1
Elevated High-Sensitivity Troponin and NT-proBNP Values in Febrile Children.发热儿童中高敏肌钙蛋白和 N 末端脑利钠肽前体值升高。
Pediatr Emerg Care. 2024 Feb 1;40(2):108-113. doi: 10.1097/PEC.0000000000003097. Epub 2023 Dec 20.
2
Multidisciplinary approach to patients with manifestations and pulmonary complications of cystic fibrosis.多学科方法治疗有囊性纤维化表现和肺部并发症的患者。
Rom J Morphol Embryol. 2020 Apr-Jun;61(2):397-406. doi: 10.47162/RJME.61.2.09.
3
Clinical presentation and early predictors for poor outcomes in pediatric myocarditis: A retrospective study.

本文引用的文献

1
N-terminal natriuretic peptide and ventilation-perfusion lung scan in sickle cell disease and thalassemia patients with pulmonary hypertension.N端利钠肽与通气灌注肺扫描在镰状细胞病和地中海贫血合并肺动脉高压患者中的应用
Hemoglobin. 2010;34(1):78-94. doi: 10.3109/03630260903554621.
2
Cardiac assessment of patients with late stage Duchenne muscular dystrophy.晚期杜氏肌营养不良症患者的心脏评估。
Neth Heart J. 2009 Jun;17(6):232-7. doi: 10.1007/BF03086253.
3
Early N-terminal pro-brain natriuretic peptide measurements predict clinically significant ductus arteriosus in preterm infants.
儿童心肌炎不良结局的临床表现及早期预测因素:一项回顾性研究。
World J Clin Cases. 2019 Mar 6;7(5):548-561. doi: 10.12998/wjcc.v7.i5.548.
4
N-terminal pro-B-type natriuretic peptide in the circulation of fetuses with cardiac malformations.循环中 N 端脑利钠肽前体与胎儿心脏畸形。
Clin Res Cardiol. 2012 Feb;101(2):73-9. doi: 10.1007/s00392-011-0366-4. Epub 2011 Sep 29.
早期N末端脑钠肽前体测量可预测早产儿临床上显著的动脉导管未闭。
Acta Paediatr. 2009 Aug;98(8):1254-9. doi: 10.1111/j.1651-2227.2009.01315.x. Epub 2009 Apr 30.
4
The use of B-type natriuretic peptide in paediatric patients: a review of literature.B型利钠肽在儿科患者中的应用:文献综述
J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):298-302. doi: 10.2459/JCM.0b013e32832401d6.
5
Intravenous luteinizing hormone-releasing hormone has no effect on serum N-terminal pro-brain natriuretic peptide in children and adolescents.静脉注射促黄体生成激素释放激素对儿童和青少年的血清N末端脑钠肽前体没有影响。
Pediatr Int. 2009 Apr;51(2):283-8. doi: 10.1111/j.1442-200X.2008.02710.x.
6
Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease.利钠肽作为川崎病急性期的辅助诊断检测方法。
Pediatr Cardiol. 2009 Aug;30(6):810-7. doi: 10.1007/s00246-009-9441-2. Epub 2009 Apr 14.
7
Elevated plasma levels of N-terminal pro-brain natriuretic peptide in children with acute poststreptococcal glomerulonephritis.急性链球菌感染后肾小球肾炎患儿血浆N末端脑钠肽前体水平升高。
Tohoku J Exp Med. 2009 Apr;217(4):295-8. doi: 10.1620/tjem.217.295.
8
Natriuretic peptides in cardiovascular diseases of fetus, infants and children.胎儿、婴幼儿及儿童心血管疾病中的利钠肽
Cardiovasc Hematol Agents Med Chem. 2009 Jan;7(1):43-51. doi: 10.2174/187152509787047667.
9
N-terminal probrain natriuretic peptide and patent ductus arteriosus in preterm infants.早产儿的N端脑钠肽前体与动脉导管未闭
J Perinatol. 2009 Feb;29(2):137-42. doi: 10.1038/jp.2008.185. Epub 2008 Nov 20.
10
Association between renal function and circulating levels of natriuretic peptides (from the Dallas Heart Study).肾功能与利钠肽循环水平之间的关联(来自达拉斯心脏研究)
Am J Cardiol. 2008 Nov 15;102(10):1394-8. doi: 10.1016/j.amjcard.2008.07.018. Epub 2008 Sep 11.